The Mpl receptor (Mpl-R) is a cytokine receptor belonging to the hemat
opoietin receptor superfamily for which a ligand has been recently cha
racterized. To study the lineage distribution of Mpl-R in normal hemat
opoietic cells, we developed a monoclonal antibody (designated M1 MoAb
) by immunizing mice with a soluble form of the human Mpl-R protein. W
ith few exceptions, Mpl-R was detected by indirect immunofluorescent a
nalysis on all human leukemic hematopoietic cell lines with pluripoten
tial and megakaryocytic phenotypes, but not on other cell lines. By im
munoprecipitation and immunoblotting, M1 MoAb recognized a band at 82
to 84 kD corresponding to the expected size of the glycosylated recept
or. Among normal hematopoietic cells, M1 MoAb strongly stained megakar
yocytes (MK) and Mpl-R was detected on platelets by indirect immunoflu
orescence staining or immunoblotting. On purified CD34(+) cells, less
than 2% of the population was stained, but the labeling was weak and j
ust above the threshold of detection. However, dual-labeling with the
M1 and antiplatetet glycoprotein MoAbs showed that most Mpl-R(+)/CD34(
+) cells coexpressed CD41a, CD61, or CD42a, suggesting that cell surfa
ce appearance of Mpl-R and platelet glycoproteins could be coordinated
. M1-positive and M1-negative subsets were sorted from purified CD34() cell populations. Colony assays showed that the absolute number of h
ematopoietic progenitors was extremely low and no primitive progenitor
s were present in the CD34(+)/ Mpl-R(+) fraction. However, this cell f
raction was significantly enriched in low proliferative colony-forming
units-MK. When the CD34(+)/Mpl-R(+) fraction was grown in liquid cult
ure containing human aplastic serum and a combination of growth factor
s, mature MK were seen as early as day 4, whereas the predominant cell
population was erythroblasts on day 8. Similar data were also obtaine
d with the CD34(+)/Mpl-R(-)fraction with, however, a delay in the time
of appearance of both MK and erythroblasts. In conclusion, Mpl-R is a
cytokine receptor restricted to the MK cell lineage. Its expression i
s low on CD34(+) cells and these cells mainly correspond to late MK pr
ogenitors and transitional cells. These data indicate that the action
of the Mpl-R ligand might predominate during the late stages of human
MK differentiation. (C) 1995 by The American Society of Hematology.